Su-jeong park*
Answering the worldwide need to give proof on the effect of interruptions and their moderation, the COVID-19 and Cancer Global Modeling Consortium (CCGMC) was laid out in May 2020. The CCGMC plans to orchestrate pertinent proof on COVID-19 and disease and arrange demonstrating stages that illuminate decision-production in malignant growth control. The CCGMC has created three interrelated work streams, measuring the effect of COVID-19 on malignant growth results, screening and analysis, and disease risk. The accentuation is on creating framework that will permit scattering of persistently refreshed short-and long haul projections of malignant growth significant results. There is a significant spotlight on assessing likely prioritization and recuperation methodologies during and following the serious social and wellbeing administrations interruptions experienced around the world.
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi